Stenting vs above knee polytetrafluoroethylene bypass for TransAtlantic Inter-Society Consensus-II C and D superficial femoral artery disease

Journal of Vascular Surgery

Volumn 48, Issue 5, 2008, Pages 1166-1174

  Dosluoglu, Hasan H ^a,b   Cherr, Gregory S ^b   Lall, Purandath ^a,b   Harris, Linda M ^b   Dryjski, Maciej L ^b  

^a VA WESTERN NEW YORK HEALTHCARE SYSTEM   (United States)

^b UNIVERSITY AT BUFFALO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

POLITEF;

ADULT; AGED; ARTERY DISEASE; ARTERY LESION; ARTICLE; BYPASS SURGERY; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; MEDICAL SOCIETY; PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY; PRIORITY JOURNAL; STENT; SUPERFICIAL FEMORAL ARTERY; SURGICAL TECHNIQUE;

AGED; AGED, 80 AND OVER; ANGIOPLASTY, BALLOON; ARTERIAL OCCLUSIVE DISEASES; BLOOD VESSEL PROSTHESIS; BLOOD VESSEL PROSTHESIS IMPLANTATION; FEMALE; FEMORAL ARTERY; HUMANS; ISCHEMIA; LOWER EXTREMITY; MALE; MIDDLE AGED; PATIENT SELECTION; POLYTETRAFLUOROETHYLENE; PRACTICE GUIDELINES AS TOPIC; PROSTHESIS DESIGN; REGISTRIES; REOPERATION; RETROSPECTIVE STUDIES; SEVERITY OF ILLNESS INDEX; STENTS; TIME FACTORS; TREATMENT OUTCOME; VASCULAR PATENCY;

EID: 55049088424     PISSN: 07415214     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jvs.2008.06.006     Document Type: Article

References (39)

1. Surowiec S.M., Davies M.G., Eberly S.W., Rhodes J.M., Illig K.A., Shortell C.K., et al. Percutaneous angioplasty and stenting of the superficial femoral artery. J Vasc Surg 41 (2005) 269-278
2. Gray B.H., and Olin J.W. Limitations of percutaneous transluminal angioplasty with stenting for femoropopliteal arterial occlusive disease. Sem Vasc Surg 10 (1997) 8-16
3. Cheng S.W.K., Ting A.C.W., and Ho P. Angioplasty and primary stenting of high-grade, long-segment disease: is it worthwhile?. Ann Vasc Surg 17 (2003) 430-437
4. Lugmayr H.F., Holzer H., Kastner M., Riedelsberger H., and Auterith A. Treatment of complex arteriosclerotic lesions with nitinol stents in the superficial femoral and popliteal arteries: a mid-term follow-up. Radiology 222 (2002) 37-43
5. Sabeti S., Mlekusch W., Amighi J., et al. Primary patency of long-segment self-expanding nitinol stents in the femoropopliteal arteries. J Endovasc Ther 12 (2005) 6-12
6. Ferreira M., Lanziotti L., Monteiro M., Abuhadba G., Capotorto L.F., Nolte L., et al. Superficial femoral artery recanalization with self-expanding nitinol stents: long-term follow-up results. Eur J Vasc Endovasc Surg 34 (2007) 702-708
7. Meuwissen M.W. Self-expanding nitinol stents in the femoropopliteal segment; technique and mid-term results. Tech Vasc Interv Radiol 7 (2004) 2-5
8. Schillinger M., Sabeti S., Loewe C., Dick P., Amighi J., Mlekusch W., et al. Balloon angioplasty versus implantation of nitinol stents in superficial femoral artery. N Engl J Med 354 (2006) 1879-1888
9. Schlager O., Dick P., Sabeti S., Amighi J., Mlekusch W., Minar E., and Schillinger M. Long-segment SFA stenting-the dark sides: in-stent restenosis, clinical deterioration, and stent fractures. J Endovasc Ther 12 (2005) 676-684
10. Loftus I.M., Hayes P.D., and Bell P.R. Subintimal angioplasty in lower limb ischemia. J Cardiovasc Surg (Torino) 45 (2004) 217-229
11. Laxdal E., Jenssen G.L., Pedersen G., and Aune S. Subintimal angioplasty as a treatment of superficial femoral artery occlusions. Eur J Vasc Endovasc Surg 25 (2003) 578-582
12. Yilmaz S., Sindel T., Yegin A., and Luleci E. Subintimal angioplasty of long superficial femoral artery occlusions. J Vasc Interv Radiol 14 (2003) 997-1010
13. Lipsitz E.C., Veith F.J., and Ohki T. The value of subintimal angioplasty in the management of critical lower extremity ischemia: failure is not always associated with a threatened limb. J Cardiovasc Surg (Torino) 45 (2004) 231-237
14. Hynes N., Akhtar Y., Manning B., Aremu M., Oiakhinan K., Courtney D., and Sultan S. Subintimal angioplasty as a primary modality in the management of critical limb ischemia; Comparison to bypass grafting for aortoiliac and femoropopliteal occlusive disease. J Vasc Ther 11 (2004) 460-471
15. Flørenes T., Bay D., Sandbaek G., Saetre T., Jørgensen J.J., Slagsvold C.E., et al. Subintimal angioplasty in the treatment of patients with intermittent claudication: long term results. Eur J Vasc Endovasc Surg 28 (2004) 645-650
16. Saxon R.R., Coffman J.M., Gooding J.M., Natuzzi E., and Ponec D.J. Long-term results of ePTFE stent-graft versus angioplasty in the femoropopliteal artery: single center experience from a prospective randomized trial. J Vasc Interv Radiol 14 (2003) 303-311
17. Lammer J., Dake M.D., Bleyn J., Katzen B.T., Cejna M., Piquet P., et al. Peripheral arterial obstruction: Prospective study of treatment with a transluminally placed self-expanding stent graft. International Trial Study Group. Radiology 217 (2000) 95-104
18. Deutschmann H.A., Schedlbauer P., Berczi V., Portugaller H., Tauss J., and Hausegger K.A. Placement of Hemobahn stent graft in femoropopliteal arteries: early experience and mid-term results in 18 patients. J Vasc Interv Radiol 12 (2001) 943-950
19. Ko Y.G., Kim J.S., Choi D.H., Jang Y., and Shim W.H. Improved technical success and midterm patency with subintimal angioplasty compared to intraluminal angioplasty in long femoropopliteal occlusions. J Endovasc Ther 14 (2007) 374-381
20. Dormandy J.A., and Rutherford R.B. Management of peripheral arterial disease (PAD). TASC Working Group. TransAtlantic Inter-Society Consensus (TASC). J Vasc Surg 31 (2000) S1-S296
21. Norgren L., Hiatt W.R., Dormandy J.A., Nehler M.R., Harris K.A., Fowkes F.G., and TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg 45 suppl S (2007) S5-S67
22. Kedora J., Hohmann S., Garrett W., Munschaur C., Theune B., and Gable D. Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral artery occlusive disease. J Vac Surg 45 (2007) 10-16
23. Klinkert P., Schepers A., Burger D.H., van Bockel J.H., and Breslau P.J. Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting: five-year results of a randomized controlled trial. J Vasc Surg 37 (2003) 149-155
24. AbuRahma A.F., Robinson P.A., and Holt S.M. Prospective controlled study of polytetrafluoroethylene versus saphenous vein in claudicant patients with bilateral femoropopliteal bypasses. Surgery 126 (1999) 594-601
25. Ballotta E., Renon L., Toffano M., and Da Giau G. Prospective randomized study on bilateral above-knee femoropopliteal revascularization: polytetrafluoroethylene graft versus reversed saphenous vein. J Vasc Surg 38 (2003) 1051-1055
26. Veith F.J., Gupta S.K., Ascher, White-Flores S., Samson S.H., Scher L.A., et al. Six-year, prospective multicenter randomized comparison of autologous saphenous vein and expanded polytetrafluoroethylene grafts in infrainguinal arterial reconstructions. J Vasc Surg 3 (1986) 104-114
27. Prendiville E.J., Yeager A., O'Donnell T.F., Coleman J.C., Jaworek A., Callow A.D., et al. Long-term results with the above-knee popliteal expanded polytetrafluoroethylene graft. J Vasc Surg 11 (1990) 517-524
28. Klinkert P., Post P.N., Breslau P.N., and van Bockel J.H. Saphenous vein versus PTFE for above-knee femoropopliteal bypass: a review of the literature. Eur J Vasc Endovasc Surg 27 (2004) 357-362
29. Pereira C.E., Albers M., Romiti M., Brochado-Neto F.C., and Pereira C.A.B. Meta-analysis of femoropopliteal bypass grafts for lower extremity arterial insufficiency. J Vasc Surg 44 (2006) 510-517
30. Ahn S.S., Rutherford R.B., Becker G.J., Comerota A.J., Johnston K.W., McClean G.K., et al. Reporting standards for lower extremity arterial endovascular procedures. Society for Vascular Surgery/International Society for Cardiovascular Surgery. J Vasc Surg 17 (1993) 1103-1107
31. DeRubertis B.G., Pierce M., Chaer R.A., Rhee S.J., Benjeloun R., Ryer E.J., et al. Lesion severity and treatment complexity are associated with outcome after percutaneous infra-inguinal intervention. J Vasc Surg 46 (2007) 709-716
32. Kudo T., Chandra F.A., and Ahn S.S. The effectiveness of PTA for the treatment of CLI: a 10 year experience. J Vasc Surg 41 (2005) 423-435
33. Bakken A.M., Palchik E., Hart J.P., Rhodes J.M., Saad W.E., and Davies M.G. Impact of diabetes mellitus on outcomes of superficial femoral artery endoluminal interventions. J Vasc Surg 46 (2007) 946-958
34. Conrad M.F., Cambria R.P., Stone D.H., Brewster D.C., Kwolek C.J., Watkins M.T., et al. Intermediate results of percutaneous endovascular therapy of femoropopliteal occlusive disease: a contemporary series. J Vasc Surg 44 (2006) 762-769
35. DeRubertis B.G., Pierce M., Ryer E.J., Trocciola S., Kent K.C., and Faries P.L. Reduced primary patency rate in diabetic patients after percutaneous intervention results from more frequent presentation with limb-threatening ischemia. J Vasc Surg 47 (2008) 101-108
36. Lazaris A.M., Tsiamis A.C., Fishwick G., Bolia A., and Bell P.R. Clinical outcome of primary infrainguinal subintimal angioplasty in diabetic patients with critical limb ischemia. J Endovasc Ther 11 (2004) 447-453
37. Dick F., Diehm N., Galimanis A., Husmann M., Schimidli J., and Baumgartner I. Surgical and endovascular revascularization in patients with critical limb ischemia: influence of diabetes mellitus on clinical outcome. J Vasc Surg 45 (2007) 751-761
38. Galaria I.I., Surowiec S.M., Rhodes J.M., Shortell C.K., Illig K.A., and Davies M.G. Implications of early failure of superficial femoral artery endoluminal interventions. Ann Vasc Surg 19 (2005) 787-792
39. Joels C.S., York J.W., Kalbaugh C.A., Cull D.L., Langan E.M., and Taylor S.M. Surgical implications of early failed endovascular intervention of the superficial femoral artery. J Vasc Surg 47 (2008) 562-565